Search Within

David R Spriggs

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (20)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (72)
  2. Biostatistics Service (68)
  3. Department of Medicine (62)
  4. Solid Tumor Oncology Division (62)
  5. Gynecology Disease Management Team (51)
  6. GDMT, Medicine (49)

More Groups

People
  1. Alexia Iasonos (42)
  2. Carol Aghajanian (42)
  3. Paul Sabbatini (36)
  4. Martee Hensley (29)
  5. Venkatraman Seshan (24)
  6. David Hyman (21)

More People

Years
  1. 2022 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (4)
  5. 2015 (7)
  6. 2014 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Gynecologic Oncology (15)
  3. Clinical Cancer Research (8)
  4. International Journal of Gynecological Cancer (5)
  5. Cancer (4)
  6. Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (16)
  3. Elsevier Inc. (15)
  4. Lippincott Williams & Wilkins (6)
  5. Wiley Blackwell (4)
  6. Oxford University Press (2)

More Publishers

Results (72)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab (Bev) for treatment of recurrent serous borderline (SB) or low-grade serous (LGS) ovarian cancer: A retrospective review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Grisham, R. N.; Sala, E.; Zhou, Q.; Iasonos, A.; DeLair, D.; Iyer, G.; Hyman, D. M.; Spriggs, D. R.; Aghajanian, C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Overexpression of the carboxyl-terminus of MUC16 can accelerate the occurrence of phenotypes in p53 heterozygous mouse model
    Meeting Abstract

    Tian, H.; Zhou, Q.; Iasonos, A.; Spriggs, D.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Identification of the MUC16/CA125 interaction network: Results of a high-throughput yeast two-hybrid screening
    Meeting Abstract

    Polterauer, S.; Thapi, D.; Schultz, N.; Ouerfelli, O.; Chen, N.; Rosales, N.; Yan, X.; Spriggs, D. R.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase i trials
    Journal Article

    Iasonos, A.; Gounder, M.; Spriggs, D. R.; Gerecitano, J. F.; Hyman, D. M.; Zohar, S.; O'Quigley, J.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer
    Journal Article

    Hyman, D. M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Arnold, A. G.; Phillips, M. F.; Bhatia, J.; Levine, D. A.; Aghajanian, C.; Offit, K.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remission
    Journal Article

    Iasonos, A.; Sabbatini, P.; Spriggs, D. R.; Aghajanian, C. A.; O'Cearbhaill, R. E.; Hensley, M. L.; Thaler, H. T.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Topoisomerase I inhibition in BRCA+ and BRCA- ovarian cancer (OC): A single-institution experience
    Meeting Abstract

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Bhatia, J.; Aghajanian, C.; Iasonos, A.; Spriggs, D. R.; Kauff, N. D.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save